1. Home
  2. TNL vs PBLS Comparison

TNL vs PBLS Comparison

Compare TNL & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

N/A

Current Price

$80.33

Market Cap

3.9B

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.23

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNL
PBLS
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.4B
IPO Year
2006
2026

Fundamental Metrics

Financial Performance
Metric
TNL
PBLS
Price
$80.33
$30.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
7
Target Price
★ $88.38
$41.00
AVG Volume (30 Days)
815.6K
★ 1.1M
Earning Date
10-27-2026
11-24-2026
Dividend Yield
★ 3.07%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 4.66
N/A
Revenue
★ $4,021,000,000.00
N/A
Revenue This Year
$4.45
N/A
Revenue Next Year
$5.21
$300.17
P/E Ratio
$16.87
★ N/A
Revenue Growth
★ 4.06
N/A
52 Week Low
$60.34
$22.66
52 Week High
$81.00
$42.49

Technical Indicators

Market Signals
Indicator
TNL
PBLS
Relative Strength Index (RSI) 76.29 52.61
Support Level $71.82 $26.42
Resistance Level N/A $33.65
Average True Range (ATR) 2.51 2.17
MACD 1.08 0.64
Stochastic Oscillator 98.97 80.19

Price Performance

Historical Comparison
TNL
PBLS

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: